On 12/9/24, Trxade Health Inc (NASDAQ: MEDS) stock enjoyed a major increase of 11.1%, closing at $7.41. Trading volume in this advance was normal. Relative to the market the stock has been weak over the last nine months but has risen 0.8% during the last week.
Current PriceTarget Research Rating
Trxade Health has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Trxade Health has a poor Power Rating of 23 and a very low Appreciation Score of 2, with the Lowest Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment